Thus, NRF2 has become a potential therapeutic target to prevent the progression of neurodegeneration, and the NRF2-PINK1 pathway is also expected to be an emerging target to counteract mitochondrial dysfunction and its consequences in PD. This evidence concerns the gene NFE2L2 and Parkinson disease.